CRIS Current Research Information System

CROCI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.391
EU - Europa 1.450
AS - Asia 1.444
AF - Africa 138
SA - Sud America 79
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.506
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.358
VN - Vietnam 407
CN - Cina 400
SG - Singapore 397
GB - Regno Unito 382
DE - Germania 196
IT - Italia 179
SE - Svezia 164
HK - Hong Kong 105
UA - Ucraina 93
RU - Federazione Russa 91
CH - Svizzera 67
FR - Francia 62
IN - India 60
BR - Brasile 54
IE - Irlanda 52
CI - Costa d'Avorio 46
TG - Togo 39
ZA - Sudafrica 32
JP - Giappone 29
CA - Canada 28
NL - Olanda 28
EE - Estonia 26
BG - Bulgaria 25
FI - Finlandia 22
BE - Belgio 18
RO - Romania 14
KR - Corea 11
AR - Argentina 9
LT - Lituania 9
ID - Indonesia 8
NG - Nigeria 7
PL - Polonia 7
SC - Seychelles 7
CL - Cile 5
IR - Iran 5
JO - Giordania 5
CO - Colombia 4
GR - Grecia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BD - Bangladesh 3
EC - Ecuador 3
EG - Egitto 3
ES - Italia 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
HR - Croazia 2
MX - Messico 2
PK - Pakistan 2
TR - Turchia 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GH - Ghana 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
ZM - Zambia 1
Totale 5.506
Salva come PNG Salva come JPEG
Città #
Southend 318
Chandler 317
Singapore 269
Fairfield 268
Ashburn 265
Woodbridge 127
Seattle 123
Wilmington 123
Houston 120
Ann Arbor 106
Hong Kong 104
Ho Chi Minh City 90
Dong Ket 87
Cambridge 85
Princeton 75
Santa Clara 70
Hanoi 66
Jacksonville 59
Bern 58
Beijing 55
Dublin 52
Abidjan 46
Hefei 46
Boardman 45
Lomé 39
Westminster 32
Nanjing 31
Padova 29
Tokyo 28
Bologna 27
Sofia 25
Bremen 24
Dallas 23
Los Angeles 22
Milan 22
Jinan 21
Berlin 20
Brussels 18
Helsinki 18
New York 18
Redwood City 18
Shenyang 17
Guangzhou 16
Ottawa 16
Falkenstein 15
Saint Petersburg 15
Buffalo 14
Changsha 12
Turin 12
Hebei 11
Nanchang 11
Phoenix 11
Seoul 11
Redondo Beach 10
San Diego 10
Haiphong 9
London 9
Mülheim 9
San Jose 9
Tianjin 9
Toronto 9
Zhengzhou 9
Da Nang 8
Jiaxing 8
Moscow 8
Bengaluru 7
Dearborn 7
Frankfurt am Main 7
Hải Dương 7
Jakarta 7
Kuban 7
Mahé 7
Abeokuta 6
Amsterdam 6
Des Moines 6
São Paulo 6
Yubileyny 6
Amman 5
Bulle 5
Bühl 5
Ha Long 5
Ningbo 5
Taizhou 5
Warsaw 5
Washington 5
Bắc Ninh 4
Johannesburg 4
Leawood 4
Quảng Ninh 4
Redmond 4
Stockholm 4
Taiyuan 4
Verona 4
Zanjan 4
Biên Hòa 3
Cagliari 3
Can Tho 3
Chicago 3
Chieti 3
Chongqing 3
Totale 3.830
Salva come PNG Salva come JPEG
Nome #
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. 354
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome 242
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 222
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R 216
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. 198
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. 194
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy 187
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor 187
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. 184
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 176
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. 175
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines 167
In silico modeling and in vivo efficacy of cancer preventive vaccinations 167
Antimetastatic activity of a preventive cancer vaccine. 167
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis 165
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 162
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. 161
Isolation and in vitro differentiation of human Mesenchymal Stem Cells from new alternative sources: fetal membranes and placenta 160
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 159
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells 155
Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. 154
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 149
Immunological prevention of a multigene cancer syndrome 147
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. 144
Translational immunomics of cancer prevention. 143
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. 141
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent 136
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells 136
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine 128
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system 127
Toward the definition of immunosuppressive regimens with antitumor activity. 113
Expression of T cell receptor alpha gene (TCRA) in human rhabdomyosarcoma and other musculo-skeletal sarcomas. 103
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes 103
null 95
Totale 5.617
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021307 0 0 0 0 0 0 8 28 61 30 25 155
2021/2022699 66 17 55 24 54 27 18 48 26 57 178 129
2022/2023981 117 146 61 146 54 71 21 46 128 38 68 85
2023/2024209 9 41 7 26 17 48 12 18 5 11 6 9
2024/2025706 55 85 56 33 126 53 39 26 6 42 33 152
2025/20261.009 305 142 141 124 192 87 18 0 0 0 0 0
Totale 5.617